NewsIMTSIIT Madras researchers have patented a cost-effective, minimally invasive glucose monitoring device for diabetes patients on November 6, 2025. The team led by Professor Parasuraman Swaminathan developed this user-friendly device at the Electronic Materials and Thin Films Lab. Today, India has 10.1 crore people living with diabetes who mostly rely on finger-prick blood samples. From next week, this new modular system will combine reusable electronics with a disposable microneedle sensor patch, eliminating the need for painful finger pricks. Until the official launch, the team is finalizing production details. The domestically developed continuous glucose monitor will strengthen India's self-reliance in medical technology while creating opportunities for local manufacturing. The device promises to make diabetes monitoring more comfortable, accessible and affordable while maintaining accuracy and reliability. (Updated 6 Nov 2025, 20:54 IST; source: link)
IIT Madras Creates Pain-Free Glucose Monitor
Researchers at IIT Madras have patented a new device that checks blood sugar levels without painful finger pricks. Led by Professor Parasuraman Swaminathan at the Electronic Materials and Thin Films Lab, the team developed this technology to help India's 10.1 crore diabetes patients. The system combines reusable electronic parts with a disposable patch containing tiny microneedles that can measure glucose with minimal discomfort. This innovation will be especially important in India, where diabetes is common but regular monitoring is often avoided due to pain and cost concerns.
How the New Glucose Monitor Works
The patented device uses a modular design with two main components: a reusable electronic unit and a disposable microneedle sensor patch. When placed on the skin, the tiny needles painlessly access fluid just below the skin surface to measure glucose levels, eliminating the need for blood samples. The team is currently finalizing production details before its official launch next week. This domestically developed technology aims to make diabetes monitoring more accessible and affordable for millions of Indians. By manufacturing the device locally, the innovation also supports India's self-reliance in medical technology while maintaining accuracy comparable to traditional methods.
Key Points
- IIT Madras researchers have patented a cost-effective, minimally invasive glucose monitoring device for diabetes patients on November 6, 2025.
- Today, India has 10.1 crore people living with diabetes who mostly rely on finger-prick blood samples.
- The domestically developed continuous glucose monitor will strengthen India's self-reliance in medical technology while creating opportunities for local manufacturing.
